Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir
The proposed oral treatment is expected to be for five days
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
PSUs roped in to ramp up COVID-19 vaccine production
Few weeks ago, inter-ministerial teams had visited the sites of two main vaccine manufacturers in India to get their inputs on how…
Haffkine Bio-Pharma to target 22.8 crore Covaxin vials annually
It would take least at one year's time for the company to start actual production
Greater risk of brain clots from COVID-19 compared with vaccines: UK researchers
The study was based on a US health database, and so did not accrue new data on the risk of clots from AstraZeneca's vaccine…
FDA, CDC calling to halt distribution of J&J vaccine is a blow to global vaccine effort:…
Following the news that the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)…
Google commits funds for 250k vaccinations in LMIC
It also announced that it is helping to fund pop-up vaccine sites in the US and committing an additional $250 million in Ad Grants…
Working on stability data on 2 to 8 C, temp range for Sputnik V vaccine: Dr Reddy’s
He said necessary cold storage infrastructure is in place to distribute the Sputnik V vaccine in India, which would be available…
Pfizer/BioNTech’s vaccine to touch sales of $24.8 billion by 2021: GlobalData
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the…
European Commission to not renew AstraZeneca and J&J vaccine contracts at expiry: Reports
The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays…
Supply scarcity is delaying full scale production of COVID-19 vaccine: Novavax
Novavax executives had previously said full-scale vaccine production could be achieved by mid-year
US halts J&J COVID-19 vaccine after six women under 50 develop rare blood clots
FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing…
COVID-19 survivors may face long-term complications: GlobalData
Further follow-up on the long-term effects of the disease needs to be conducted, along with treatments to prevent these outcomes
Dr Reddy’s receives EUA for Sputnik V in India
Sputnik V uses two different vectors for the two shots in a course of vaccination and its efficacy was determined to be 91.6 per…
SEC of CDSCO recommends approval to Sputnik V for EUA in India
The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India
China mulls combining COVID-19 vaccines to enhance protection rate
Available data shows Chinese vaccines lag behind others including Pfizer and Moderna in terms of efficacy, but require less…
Centre bans exports of remdesivir until COVID situation gets better
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre said the export of the antiviral injection…
Iran in discussions with India for second shipment of COVID-19 vaccines
India has scaled down the export of coronavirus vaccines following a surge in the demand for those within the country in view of a…
SII is legally bound to supply COVID-19 vaccines: COVAX
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200…
J&J in discussions with Indian regulator to begin trial of single-dose vaccine
India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme
SII repays South Africa for COVID-19 vaccines that were not delivered
A million doses that had already been delivered, have been sold on to other countries in the African Union